Advanced Medical Isotope Price to Free Cash Flow Ratio 2013-2025 | RDGL
Historical price to free cash flow ratio values for Advanced Medical Isotope (RDGL) since 2013.
| Advanced Medical Isotope Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-04-20 | 0.07 | 0.00 | |
| 2025-12-31 | 0.07 | 0 | 0.00 |
| 2025-09-30 | 0.09 | $0.00 | 0.00 |
| 2025-06-30 | 0.11 | $0.00 | 0.00 |
| 2025-03-31 | 0.12 | $0.00 | 0.00 |
| 2024-12-31 | 0.11 | $0.00 | 0.00 |
| 2024-09-30 | 0.16 | $0.00 | 0.00 |
| 2024-06-30 | 0.20 | $0.00 | 0.00 |
| 2024-03-31 | 0.07 | $0.00 | 0.00 |
| 2023-12-31 | 0.07 | $0.00 | 0.00 |
| 2023-09-30 | 0.07 | $0.00 | 0.00 |
| 2023-06-30 | 0.05 | $0.00 | 0.00 |
| 2023-03-31 | 0.07 | $0.00 | 0.00 |
| 2022-12-31 | 0.04 | $0.00 | 0.00 |
| 2022-09-30 | 0.05 | $0.00 | 0.00 |
| 2022-06-30 | 0.07 | $0.00 | 0.00 |
| 2022-03-31 | 0.07 | $0.00 | 0.00 |
| 2021-12-31 | 0.08 | $0.00 | 0.00 |
| 2021-09-30 | 0.12 | $0.00 | 0.00 |
| 2021-06-30 | 0.12 | $0.00 | 0.00 |
| 2021-03-31 | 0.10 | $0.00 | 0.00 |
| 2020-12-31 | 0.11 | $0.00 | 0.00 |
| 2020-09-30 | 0.03 | $0.00 | 0.00 |
| 2020-06-30 | 0.04 | $0.00 | 0.00 |
| 2020-03-31 | 0.03 | $0.00 | 0.00 |
| 2019-12-31 | 0.04 | $0.00 | 0.00 |
| 2019-09-30 | 0.04 | $-0.01 | 0.00 |
| 2019-06-30 | 0.03 | $-0.01 | 0.00 |
| 2019-03-31 | 0.02 | $-0.01 | 0.00 |
| 2018-12-31 | 0.06 | $-0.01 | 0.00 |
| 2018-09-30 | 0.14 | $-0.05 | 0.00 |
| 2018-06-30 | 0.02 | $-0.09 | 0.00 |
| 2018-03-31 | 0.24 | $-0.16 | 0.00 |
| 2017-12-31 | 0.40 | $-0.21 | 0.00 |
| 2017-09-30 | 0.57 | $-0.23 | 0.00 |
| 2017-06-30 | 0.66 | $-0.26 | 0.00 |
| 2017-03-31 | 1.21 | $-0.54 | 0.00 |
| 2016-12-31 | 1.40 | $-0.72 | 0.00 |
| 2016-09-30 | 1.68 | $-0.90 | 0.00 |
| 2016-06-30 | 2.96 | $-0.85 | 0.00 |
| 2016-03-31 | 3.76 | $-0.62 | 0.00 |
| 2015-12-31 | 1.84 | $-0.52 | 0.00 |
| 2015-09-30 | 1.12 | $-0.35 | 0.00 |
| 2015-06-30 | 0.72 | $1.31 | 0.55 |
| 2015-03-31 | 2.80 | $0.24 | 11.74 |
| 2014-12-31 | 0.72 | $-2.85 | 0.00 |
| 2014-09-30 | 2.88 | $-4.44 | 0.00 |
| 2014-06-30 | 17.52 | $-8.34 | 0.00 |
| 2014-03-31 | 39.84 | $-14.31 | 0.00 |
| 2013-12-31 | 50.40 | $-16.18 | 0.00 |
| 2013-09-30 | 38.40 | $-17.38 | 0.00 |
| 2013-06-30 | 48.00 | $-22.78 | 0.00 |
| 2013-03-31 | 100.80 | $3,298.27 | 0.03 |
| 2012-12-31 | 148.00 | $-19.03 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.038B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $12.989B | 9.05 |
| Blackstone Secured Lending Fund (BXSL) | United States | $5.373B | 7.18 |
| Blue Owl Technology Finance (OTF) | United States | $5.241B | 8.17 |
| Main Street Capital (MAIN) | United States | $4.783B | 13.07 |
| Golub Capital BDC (GBDC) | United States | $3.346B | 8.20 |
| FS KKR Capital (FSK) | United States | $2.837B | 8.89 |
| Hercules Capital (HTGC) | United States | $2.746B | 7.79 |
| Sixth Street Specialty Lending (TSLX) | United States | $1.716B | 8.25 |
| Trinity Capital (TRIN) | United States | $1.258B | 7.23 |
| Amalgamated Financial (AMAL) | United States | $1.257B | 11.51 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.229B | 7.14 |
| Goldman Sachs BDC (GSBD) | United States | $1.010B | 5.75 |
| Kayne Anderson BDC (KBDC) | United States | $0.932B | 8.38 |
| BARINGS BDC, INC (BBDC) | United States | $0.873B | 7.45 |
| SLR Investment (SLRC) | United States | $0.819B | 9.32 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.818B | 6.71 |
| New Mountain Finance (NMFC) | United States | $0.787B | 6.24 |
| Carlyle Secured Lending (CGBD) | United States | $0.773B | 7.24 |
| Fidus Investment (FDUS) | United States | $0.680B | 8.41 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.665B | 7.24 |
| Gladstone Investment (GAIN) | United States | $0.584B | 15.44 |
| Crescent Capital BDC (CCAP) | United States | $0.461B | 6.85 |
| Gladstone Capital (GLAD) | United States | $0.398B | 8.73 |
| Saratoga Investment Corp (SAR) | United States | $0.362B | 9.25 |
| CION Investment (CION) | United States | $0.349B | 3.91 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.323B | 3.05 |
| Palmer Square Capital BDC (PSBD) | United States | $0.315B | 6.05 |
| PennantPark Investment (PNNT) | United States | $0.291B | 7.19 |
| Stellus Capital Investment (SCM) | United States | $0.271B | 6.93 |
| Runway Growth Finance (RWAY) | United States | $0.238B | 4.25 |
| Horizon Technology Finance (HRZN) | United States | $0.216B | 4.35 |
| Chicago Atlantic BDC (LIEN) | United States | $0.211B | 11.83 |
| Medallion Financial (MFIN) | United States | $0.208B | 4.60 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.207B | 4.83 |
| WhiteHorse Finance (WHF) | United States | $0.168B | 6.75 |
| Oxford Square Capital (OXSQ) | United States | $0.164B | 6.03 |
| PhenixFIN (PFX) | United States | $0.083B | 14.72 |
| Advanced Flower Capital (AFCG) | United States | $0.060B | 28.44 |
| OFS Capital (OFS) | United States | $0.052B | 4.15 |
| Rand Capital (RAND) | United States | $0.033B | 8.88 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.025B | 14.33 |